Latest Regulatory Approvals News

Albion Resources has cleared a regulatory hurdle to commence its inaugural drilling at the Gidgee Gold Project, targeting a high-priority gold zone and multiple new anomalies in Western Australia's Gum Creek Belt.

eMetals Limited has secured all necessary approvals to begin a 17-hole diamond core drilling program at its Mineral Range Tungsten Project in Utah, targeting high-grade tungsten mineralisation within a historically productive mining district.

NH3 Clean Energy has raised $4 million through a private placement priced at an 18.4% discount to fund front-end engineering and design work for its WAH2 clean ammonia project, signalling strong institutional backing as it approaches key development milestones.

Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.

Osteopore has inked a three-year distribution agreement with Al-Umnia Medical to bring its 3D-printed orthopaedic implants to five Gulf countries, targeting a rapidly expanding regional market.

Hawsons Iron (ASX:HIO) is aiming to raise up to A$1.5 million through a discounted Share Purchase Plan, sweetened with free attaching unlisted options exercisable at A$0.015 each.

Promisia Healthcare is set to acquire Chatswood Retirement Village in Christchurch for $25 million, bolstering its East Christchurch presence and promising immediate earnings accretion.

Infinity Metals has locked in an exclusive option to acquire 100% of the Tule Canyon molybdenum-copper project in Nevada, a historically explored porphyry deposit with promising drill results and strategic positioning amid soaring molybdenum prices.

Heavy Rare Earths Limited (ASX:HRE) has secured $2.028 million through a placement and entitlement offer to advance drilling programs and a strategic review across its key projects in South Australia and Western Australia.

Neuren Pharmaceuticals saw a record Q2 with DAYBUE net sales hitting US$125 million, driven by strong uptake of the new STIX formulation. The company upgraded its 2026 royalty guidance following Acadia Pharmaceuticals’ sales boost and awaits key regulatory milestones in Europe and Japan.

Strata Minerals is pushing forward multiple technical workstreams at its Zelica Gold Project in Western Australia, backed by BML Ventures. These initiatives aim to de-risk mine planning, processing, and permitting as the project moves closer to development.

Cygnus Metals has lodged its draft scheme booklet with ASIC, moving closer to a planned acquisition by Central Asia Metals. Regulatory approvals in North Macedonia are complete, with Kazakhstan clearance still pending.